Patent details
EP1237552 Title: COMBINATION OF LUMILYSERGOL AND RILUZOLE FOR PREVENTING AND/OR TREATING MOTONEURONAL DISEASES
Basic Information
- Publication number:
- EP1237552
- PCT Application Number:
- PCT/FR/2000/003314
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP009814674
- PCT Publication Number:
- WO/2001/039776
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- French
- English Title of Invention:
- COMBINATION OF LUMILYSERGOL AND RILUZOLE FOR PREVENTING AND/OR TREATING MOTONEURONAL DISEASES
- French Title of Invention:
- ASSOCIATION DE LUMILYSERGOL ET RILUZOLE POUR LA PREVENTION ET/OU LE TRAITEMENT DE MALADIES MOTONEURONALES
- German Title of Invention:
- KOMBINATION VON LUMILYSERGOL UND RILUZOL FÜR DIE VORBEUGUNG UND/ODER BEHANDLUNG VON MOTONEURONALEN ERKRANKUNGEN
- SPC Number:
Dates
- Filing date:
- 28/11/2000
- Grant date:
- 17/08/2005
- EP Publication Date:
- 17/08/2005
- PCT Publication Date:
- 07/06/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/09/2002
- EP B1 Publication Date:
- 17/08/2005
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/11/2013
- Expiration date:
- 28/11/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/11/2000
- Name:
- Aventis Pharma S.A.
- Address:
- 20, avenue Raymond Aron, 92160 Antony, France (FR)
Inventor
1
- Name:
- STUTZMANN Jean-Marie
- Address:
- France (FR)
2
- Name:
- DIB Michel
- Address:
- France (FR)
Priority
- Priority Number:
- 9915139
- Priority Date:
- 01/12/1999
- Priority Country:
- France (FR)
Classification
- Main IPC Class:
- A61K 31/48;
| Filing date | Document type | Number of pages |
|---|